Marwin Gröner (@medmarwin) 's Twitter Profile
Marwin Gröner

@medmarwin

MD | Rheumatology Fellow at @JHRheumFellows | @YaleIMed & @unifau alumnus | Interested in novel therapeutics

ID: 1194102918892396544

calendar_today12-11-2019 04:01:46

187 Tweet

244 Followers

331 Following

Yale IM Traditional Residency Program (@tradimyale) 's Twitter Profile Photo

Shout out our brilliant #InternalMedicine residents presenting work at national conferences🎉! From cardiology to rheum, from GI to bioethics. Our residents can do it all! 🔬 Students and residents: check the thread for upcoming conferences that still are accepting abstracts!

Shout out our brilliant #InternalMedicine residents presenting work at national conferences🎉! From cardiology to rheum, from GI to bioethics. Our residents can do it all! 🔬 Students and residents: check the thread for upcoming conferences that still are accepting abstracts!
Johns Hopkins Rheumatology Fellows (@jhrheumfellows) 's Twitter Profile Photo

After a few days of transitioning our new first year fellows through a "Crash Course in Rheumatology", they are off with a bang!@MedMarwin Rebecca Slotkin, MD Vishal Patel, MD #AntonioSalas #Rheumfellowship #newbies

After a few days of transitioning our new first year fellows through a "Crash Course in Rheumatology", they are off with a bang!@MedMarwin <a href="/RebeccaSlotkin/">Rebecca Slotkin, MD</a> <a href="/VishPatelMD/">Vishal Patel, MD</a> #AntonioSalas
#Rheumfellowship #newbies
Michael Fralick (@fralickmike) 's Twitter Profile Photo

Need a power/sample size calculation for a study or upcoming grant? Led by Emil Hodzic-Santor, we built a simple, free, and pain-free (!) shiny app. feedback welcome plz share with interested parties. check it out: powercalc.ca 🦾🤓 Michelle Sholzberg Kieran Campbell Lianne Jeffs

Need a power/sample size calculation for a study or upcoming grant? Led by <a href="/emil_hs/">Emil Hodzic-Santor</a>,  we built a simple, free, and pain-free (!) shiny app. feedback welcome plz share with interested parties. check it out: powercalc.ca 🦾🤓

<a href="/sholzberg/">Michelle Sholzberg</a> <a href="/kieranrcampbell/">Kieran Campbell</a> <a href="/JeffsLianne/">Lianne Jeffs</a>
Myma Albayda, MD, RhMSUS (@mymaalbaydamd) 's Twitter Profile Photo

We are so proud of our 2024 Hopkins award winners! Johns Hopkins Rheumatology Phil Seo - ACR Distinguished Service Award Kamini Kuchinad - ACR Distinguished Fellow Award Victoria Ruffing - ARP Award of Merit

We are so proud of our 2024 Hopkins award winners! <a href="/jhrheumatology/">Johns Hopkins Rheumatology</a> 
Phil Seo - ACR Distinguished Service Award
Kamini Kuchinad - ACR Distinguished Fellow Award
Victoria Ruffing - ARP Award of Merit
Max Konig (@maxkonigmd) 's Twitter Profile Photo

Congrats to Jin Liu for being awarded the ACR Emerging Investigator Excellence Award for her work on 9G4-targeted CAR/cTCR-T cells for the treatment of lupus. #ACR24 Johns Hopkins Rheumatology #ProundMentorMoment

Congrats to Jin Liu for being awarded the ACR Emerging Investigator Excellence Award for her work on 9G4-targeted CAR/cTCR-T cells for the treatment of lupus. 
#ACR24 <a href="/jhrheumatology/">Johns Hopkins Rheumatology</a> #ProundMentorMoment
Johns Hopkins Rheumatology Fellows (@jhrheumfellows) 's Twitter Profile Photo

The holidays are in the air! The Rheumatology townhall never fails to put us in the 🎄 spirit! This year's program-- Two Truths a Lie (guess the lie!): 1. The Johns Hopkins Rheumatology Fellows love their fellowship program 2. Rheumatologists are a bore 3. #Baltimore is beautiful in the winter

The holidays are in the air! The Rheumatology townhall never fails to put us in the 🎄 spirit! 

This year's program-- Two Truths a Lie (guess the lie!):
1. The <a href="/JHRheumFellows/">Johns Hopkins Rheumatology Fellows</a> love their fellowship program
2. Rheumatologists are a bore
3. #Baltimore is beautiful in the winter
Max Konig (@maxkonigmd) 's Twitter Profile Photo

What are the implications for CAR-T cell therapy for autoimmune diseases? 1- we need safety switches 2- we need targeted editing approaches, not just random integration 3- we need to favor therapies that are rejected (e.g., most allogenic CAR-T cells get rejected) All exist.